Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
KRRO
#3680
Korro Bio, Inc. Common Stock
13.680
0
USD
-1.79%
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
-1.79%
Monthly Change
-0.18%
6 month change
-64.83%
Year Change
-64.83%
Previous Close
13.930
0
Open
13.680
0
Bid
Ask
Low
13.680
0
High
13.680
0
Volume
17
Markets
US Stock Market
Healthcare
KRRO
Open full chart
Financials
Overview
Statement
Statistics
Quarterly
Annual
Value
Q4, 24
Q1, 25
Q2, 25
Q3, 25
Q4, 25
TTM
Key stats
Total common shares outstanding
9.39 M
9.39 M
9.39 M
9.42 M
14.42 M
—
Valuation ratios
Enterprise value
301.79 M
99.34 M
83.68 M
426.84 M
93.7 M
703.56 M
Price to earnings ratio
-4.06
-1.85
-1.28
-5.1
-0.64
-8.87
Price to sales ratio
149.54
—
18.32
60.02
11.77
—
Price to cash flow ratio
-5.65
-2.56
-1.73
-6.54
-0.96
-11.79
Price to book ratio
2.12
0.23
0.19
0.86
1.46
2.75
Enterprise value to EBITDA ratio
-3.35
—
-0.87
-4.7
-0.79
—
Profitability ratios
Return on assets %
-0.09
-0.12
-0.14
-0.11
-0.44
-0.81
Return on equity %
-0.13
-0.17
-0.22
-0.18
-0.97
-1.55
Return on invested capital %
-100.05
-113.72
-127.89
-99.97
-394.14
-735.72
Gross margin %
100
100
100
100
100
400
Operating margin %
-1 014.53
-981.18
-1 863.15
-1 764.86
-3 900.62
-8 509.81
EBITDA margin %
-987.41
-946.47
-1 786.44
-1 659.08
-3 851.63
-8 243.62
Net margin %
-933.47
-917.14
-1 765.07
-1 656.97
-3 873.22
-8 212.4
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
8.79
9.41
5.98
6.71
6.9
29
Inventory turnover
—
—
—
—
—
—
Asset turnover
0.01
0.01
0.01
0.01
0.01
0.04
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
-0.84
-2.61
-2.05
-1.83
-1.88
-8.37
EBIT per share
-2.58
-2.67
-2.9
-2.05
-5.36
-12.98
EBITDA per share
-2.51
-2.57
-2.78
-1.93
-5.3
-12.57
Total debt per share
—
—
—
—
—
—
Cash per share
14.14
12.25
10.26
9.85
8
40.36
Net current asset value per share
14.74
12.92
10.93
10.46
8.77
43.07
Tangible book value per share
17.98
14.81
12.26
10.54
5.47
43.08
Working capital per share
13.07
11.55
9.1
8.9
7.5
37.04
Book value per share
17.98
14.81
12.26
10.54
5.47
43.08
News
Thursday’s insider buys and sells: AdaptHealth leads activity
Cantor Fitzgerald raises Korro Bio stock price target on UCD confidence
Raymond James upgrades Korro Bio stock rating on hyperammonemia pivot
Baskett Forest buys Korro Bio (KRRO) shares worth $2.3 million
Nea 17 buys Korro Bio (KRRO) shares worth $2.3 million
Korro Bio investor buys $2.3 million in KRRO stock
Korro Bio, Inc. (KRRO) Reports Q4 Loss, Lags Revenue Estimates
United Therapeutics (UTHR) Surges 10.7%: Is This an Indication of Further Gains?
Korro Bio raises $85 million in private equity financing
Korro stock surges 17% on $85M private placement financing
Collegium Pharmaceutical (COLL) Q4 Earnings and Revenues Miss Estimates
Clear Street upgrades Korro Bio stock rating on hyperammonemia program potential